{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:36:46Z","timestamp":1768340206799,"version":"3.49.0"},"reference-count":21,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,4,23]],"date-time":"2009-04-23T00:00:00Z","timestamp":1240444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Oral isotretinoin is a highly effective treatment for refractory nodulocystic acne. However, it can be associated with serious adverse effects such as teratogenicity and hepatitis. Inadequate cumulative dosing may also result in reduced therapeutic efficacy and higher disease relapse. A preliminary audit had previously revealed a poor and inconsistent adherence to local isotretinoin prescribing guidelines by physicians. To achieve greater than 90% adherence to isotretinoin guidelines for all acne patients prescribed systemic isotretinoin at the National Skin Centre, Singapore, key areas and the reasons for non\u2010adherence were identified. A specifically designed \u2018one\u2010stop\u2019 electronic isotretinoin chart was launched within the electronic medical records (EMR) system to address important safety areas; namely, informed patient consent, pregnancy testing, baseline laboratory tests, and automatic calculation of cumulative and target doses of isotretinoin. Physician adherence to prescribing guidelines improved from a baseline of 50\u201360% to greater than 90% (range 95\u2013100%) for 30 consecutive months post intervention. The e\u2010isotretinoin chart has resulted in significant improvement in physicians' adherence to isotretinoin prescription guidelines and highlights the utility of EMR technology in influencing safe prescribing behaviour among doctors.<\/jats:p>","DOI":"10.1111\/j.1440-0960.2009.00516.x","type":"journal-article","created":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T01:42:58Z","timestamp":1240537378000},"page":"107-112","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Electronic e\u2010isotretinoin prescription chart: Improving physicians' adherence to isotretinoin prescription guidelines"],"prefix":"10.1111","volume":"50","author":[{"given":"Mark BY","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene ST","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth AL","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SC","family":"Loo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SH","family":"Chua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,23]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.08.048"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.02.012"},{"key":"e_1_2_7_4_2","unstructured":"British Association of Dermatologists.Advice on the Safe Introduction and Continued Use of Isotretinoin in Acne. Available from URL:http:\/\/www.bad.org.uk\/healthcare\/guidelines\/acne.asp(accessed 1 Jun 2008)."},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1993.tb11849.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1999.00651.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(88)80249-4"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.113717"},{"key":"e_1_2_7_9_2","first-page":"78","article-title":"Isotretinoin (Ro\u2010Accutane) teratogenesis. A case report","volume":"32","author":"Giannoulis CH","year":"2005","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2004.12.017"},{"key":"e_1_2_7_11_2","unstructured":"PittsM.Isotretinoin Pregnancy Exposures: Spontaneous Reports 1\u2003year prior to and 1\u2003year after Implementation of the Current RMP. Available from URL:http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/04\/slides\/4017S1_06_Pitts.ppt(accessed 1 Jun 2008)."},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.5.563"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030483"},{"key":"e_1_2_7_14_2","unstructured":"US Food and Drug Administration.Strengthened Risk Management Program for Isotretinoin. Available from URL:http:\/\/www.fda.gov\/cder\/drug\/advisory\/isotretinoin2005.htm(accessed 1 Jun 2008)."},{"key":"e_1_2_7_15_2","unstructured":"BoodmanSG.Too hard to take: a strict new acne drug programme may prevent birth defects. But many complain it also drives people away from a potentially life\u2010transforming treatment.The Washington Post2006; 5 Sep. (HE01). Available from URL:http:\/\/www.washingtonpost.com\/wp\u2010dyn\/content\/article\/2006\/09\/03\/AR2006090300590.html(accessed 1 Jun 2008)."},{"key":"e_1_2_7_16_2","unstructured":"DarvesB.Dermatologists frustrated with problematic iPledge program.Medscape Medical News2006; 9 Mar. Available from URL:http:\/\/www.medscape.com\/viewarticle\/525664(accessed 1 Jun 2008)."},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2007.12.010"},{"issue":"4","key":"e_1_2_7_18_2","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1093\/ajhp\/57.suppl_4.S18","article-title":"Improving the quality of the order\u2010writing process for inpatient orders and outpatient prescriptions","volume":"57","author":"Meyer TA","year":"2000","journal-title":"Am. J. Health Syst. Pharm."},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2005.0194.x"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.05.018"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200427140-00001"},{"key":"e_1_2_7_22_2","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1542\/peds.111.S1.1167","article-title":"Sharing prescription medication among teenage girls: potential danger to unplanned\/undiagnosed pregnancies","volume":"111","author":"Daniel KL","year":"2003","journal-title":"Paediatrics"}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-0960.2009.00516.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-0960.2009.00516.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T01:05:59Z","timestamp":1697418359000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-0960.2009.00516.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,23]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1111\/j.1440-0960.2009.00516.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-0960.2009.00516.x","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"value":"0004-8380","type":"print"},{"value":"1440-0960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,23]]},"assertion":[{"value":"2009-04-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}